Griseofulvin

CHEMBL562 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
352.8 g/mol
LogP
2.2
Phase
4

An antifungal medication taken orally to treat fungal infections of the skin, hair, and nails, working by interfering with fungal cell division and disrupting the microtubule structure that fungi need to reproduce. Treatment typically requires several weeks to months depending on the site of infection. It has also been investigated for potential anticancer properties in cell growth studies.

น้ำหนักโมเลกุล

352.8000 g/mol

LogP

2.20

TPSA

71.10 Ų

Lipinski RO5

ผ่าน

ด้านการรักษา

กลไกการออกฤทธิ์

Disrupts microtubule dynamics by binding to tubulin, preventing the formation of the mitotic spindle and arresting cell division at metaphase. This induces apoptosis in rapidly dividing cells.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Disrupts microtubule dynamics by binding to tubulin, preventing the formation of the mitotic spindle and arresting cell division at metaphase. This induces apoptosis in rapidly dividing cells.

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O

InChI

InChI=1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1

Molecular Formula

C17H17ClO6

HBD / HBA

- / 6

พันธะที่หมุนได้

3

อะตอมหนัก

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

An antifungal medication taken orally to treat fungal infections of the skin, hair, and nails, working by interfering with fungal cell division and disrupting the microtubule structure that fungi need to reproduce. Treatment typically requires several weeks to months depending on the site of infection. It has also been investigated for potential anticancer properties in cell growth studies.

Disrupts microtubule dynamics by binding to tubulin, preventing the formation of the mitotic spindle and arresting cell division at metaphase. This induces apoptosis in rapidly dividing cells.

Yes, Griseofulvin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL562. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 441140. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.